Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Breast Cancer
•
Radiation Oncology
Is FAST-Forward/ultra-hypofractionation suitable for an early-stage breast patient after a lumpectomy with oncoplastic reduction?
Answer from: Radiation Oncologist at Community Practice
Yes, FAST-Forward is fine after oncoplastic reduction as long as dose homogeneity criteria can be met (V105 < 5%).
Comments
Radiation Oncologist at Indiana University Health
@Sushil Beriwal, is there any thought that if a pa...
Radiation Oncologist at Varian Medical Systems/Allegheny health network
As long as dosimetric and clinical criteria are me...
15540
15544
Sign in or Register to read more
26566
Related Questions
Would you forgo lumpectomy cavity boost for grade 1 papillary carcinoma with associated grade 1 DCIS that has been resected with good margins?
In what circumstances would you offer axillary re-irradiation after salvage axillary dissection?
Does delay to the time of lumpectomy impact your decision to omit radiation?
What are your top takeaways in Breast Cancer from ESMO 2024?
Would you recommend PMRT for multifocal IDC with extensive LVI and 1 SLN with ITCs?
How are you clinically incorporating the data presented from RT Charm at ASTRO 2024?
Does a post-surgical hematoma in the breast affect your recommendations for partial breast RT?
What is your approach to women with breast cancer who opts for a staged approach with up-front lumpectomy and SLN biopsy (pN-) when there are indications for adjuvant radiation therapy but she plans for a later mastectomy (=>6 months)?
Would you recommend MRI post surgery and pre-irradiation for patients with extensive DCIS and close margins and how would it impact your management?
How would you manage a patient with micrometastatic node positive tumor post mastectomy (no neoadjuvant chemotherapy)?
@Sushil Beriwal, is there any thought that if a pa...
As long as dosimetric and clinical criteria are me...